Left atrial appendage closure device implantation via transhepatic vascular access: a case report.

ABSTRACT:

Background

In patients with non-valvular atrial fibrillation, an estimated 90% of thrombi are located in the left atrial appendage. The WATCHMAN device is a left atrial appendage closure device that is an alternative therapeutic option to reduce the risk of systemic embolization in patients who are intolerant of long-term oral anticoagulation. It can be deployed in the left atrial appendage using a transseptal approach via the femoral vein. Transhepatic venous access is an alternative route for the delivery of the device in a patient with difficult vascular access.

Case summary

An 81-year-old man with persistent non-valvular atrial fibrillation, heart failure with reduced ejection fraction (HFrEF), and diabetes mellitus was deemed a poor candidate for anticoagulation due to

SUBMITTER: Zare P 

PROVIDER: S-EPMC7891241 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature